Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Cash (2019 - 2025)

Historic Change in Cash for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $11.7 million.

  • Eton Pharmaceuticals' Change in Cash rose 35742.11% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 103200.66%. This contributed to the annual value of -$6.5 million for FY2024, which is 22693.29% down from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Change in Cash is $11.7 million, which was up 35742.11% from $8.0 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Change in Cash's 5-year high stood at $11.7 million during Q3 2025, with a 5-year trough of -$8.3 million in Q4 2021.
  • For the 5-year period, Eton Pharmaceuticals' Change in Cash averaged around $832947.4, with its median value being $823000.0 (2022).
  • Its Change in Cash has fluctuated over the past 5 years, first soared by 131933.09% in 2021, then tumbled by 68079.18% in 2024.
  • Eton Pharmaceuticals' Change in Cash (Quarter) stood at -$8.3 million in 2021, then surged by 135.25% to $2.9 million in 2022, then crashed by 123.3% to -$682000.0 in 2023, then plummeted by 680.79% to -$5.3 million in 2024, then surged by 320.51% to $11.7 million in 2025.
  • Its Change in Cash was $11.7 million in Q3 2025, compared to $8.0 million in Q2 2025 and $2.5 million in Q1 2025.